Delivery Order SPE2DB22D3301-SPE2DB25FX9QB

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp (ABDC) is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers a broad range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific order awarded is for OTEZLA 30 MG TABLET 60S, with a...
This federal contract award to AmerisourceBergen Drug Corp (ABDC) is for the delivery of OTEZLA 30 mg tablets to various federal agencies, predominantly the Defense Logistics Agency (DLA). The $4,563.11 firm-fixed-price contract has a completion date of July 15, 2024 and was awarded on July 12, 2024. ABDC is an experienced pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical and a...
This federal contract award, valued at $16,781.56, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA) and is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $79,434.26, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,761.82 firm fixed price delivery order is for the supply of OTEZLA 30 MG TAB 60S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $4,436.68 firm-fixed-price delivery order is for the pharmaceutical product Otezla 30 mg tablet (60 count). This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $15,416.90 firm fixed-price delivery order is for the supply of Otezla 30mg tablets. The contract has an ultimate completion date of October 18, 2024. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $10,924.25. The contract is for the pharmaceutical product OTEZLA 30 MG TABLET 60S, with a period of performance through December 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor on this contract, which does not have a set-aside designation. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $36,157.69 firm fixed price delivery order is for the supply of Otezla 30 mg tablets, a specialty pharmaceutical product. The award does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this delivery order, as well as for a larger...
This contract award for $26,342.84 is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Otezla 30mg tablets over the period ending on August 11, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9QB
    Delivery Order

This contract award to AmerisourceBergen Drug Corp (ABDC) is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $33,373.17 and running through February 2025. The award is for the pharmaceutical product Otezla 30 mg Tablet 60s, a medication used in the treatment of various medical conditions. As a major pharmaceutical distributor, ABDC has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This award is part of ABDC's broader $999,999,999 IDC with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This task order award demonstrates ABDC's ongoing role in supplying essential medications and medical commodities to federal agencies and healthcare institutions served by the DLA.

Generated 5/6/25, 11:58 AM